|
시장보고서
상품코드
1935221
신경질환 진단 시장 : 기술별, 질환별, 최종사용자별, 지역별Neurological Disorder Diagnostics Market, By Technology, By Disease Indication, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
신경질환 진단 시장은 2026년에 137억 6,000만 달러로 추정되며, 2033년까지 158억 7,000만 달러에 이를 것으로 예측됩니다. 2026-2033년 연평균 복합 성장률(CAGR)은 9.1%로 전망됩니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 137억 6,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.10% | 2033년 예측 : | 158억 7,000만 달러 |
신경질환 진단 도구는 알츠하이머병, 파킨슨병, 헌팅턴병 등 다양한 신경질환의 진단에 사용됩니다. 신경질환은 영상진단 기술이나 체외진단 기술을 이용하여 진단할 수 있습니다. 영상진단 기술로는 컴퓨터단층촬영(CT), 자기공명영상법(MRI) 등이 사용되며, 장기, 뼈, 연부조직, 혈관, 기타 신체 부위의 상세한 영상을 생성합니다. 한편 체외 진단 기술에는 생검, 바이오마커 검사, 혈액 검사, 소변 검사, 유전자 검사 등이 있습니다.
시장 역학
신경질환 진단기기의 기술 혁신과 개발이 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2017년 Neusoft Medical Systems는 혁신적인 CT 스캐너 'NeuViz Prime CT Scanner'를 개발하여 미국 식품의약국(FDA)의 승인을 받았습니다. 또한 2016년에는 Koninklijke Philips N.V.사가 캐나다에서 'IQon Spectral CT'를 출시하였습니다. IQon Spectral CT는 스펙트럼 이미징 전용으로 설계된 스펙트럼 검출기 CT입니다.
본 조사의 주요 특징
- 이 보고서는 2018년을 기준 연도로 하여 예측 기간(2019-2027년) 시장 규모와 예측 기간(2019-2027년)의 연평균 성장률(CAGR)을 제시하는 세계 신경 질환 진단 시장에 대한 상세한 분석을 제공합니다.
- 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명할 것입니다.
- 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 기업 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략, 미래 계획 등 다양한 매개 변수를 기반으로 세계 신경 질환 진단 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 신경 질환 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 신경질환 진단 시장 분석에 사용된 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 신경질환 진단 시장 : 기술별, 2026-2033년
제5장 세계의 신경질환 진단 시장 : 질환별, 2026-2033년
제6장 세계의 신경질환 진단 시장 : 최종사용자별, 2026-2033년
제7장 세계의 신경질환 진단 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 애널리스트 추천 사항
제10장 섹션
LSH 26.03.10Neurological Disorder Diagnostics Market is estimated to be valued at USD 13.76 Bn in 2026 and is expected to reach USD 15.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 13.76 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.10% | 2033 Value Projection: | USD 15.87 Bn |
Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and others. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostic techniques. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels, and other parts of body. Whereas, in-vitro diagnostic techniques include biopsy, biomarker, blood test, urine test, and genetic testing.
Market Dynamics
Technological innovations and developments in neurological disorder diagnosing devices are expected to drive the market growth. For instance, in 2017, Neusoft Medical Systems developed an innovative CT scanner NeuViz Prime CT Scanner and received the U.S. Food and Drug Administration approval for the system. Moreover in 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging.
Key features of the study
- This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neurological disorder diagnostics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics
- The global neurological disorder diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurological disorder diagnostics market
Market Segmentation
- By Technology
- Imaging
- In Vitro Diagnostics
- By Disease Indication
- Genetic Neurological Disorders
- Immunological Neurological Disorders
- Paraneoplastic Syndrome
- Paraproteinemic Neuropathies
- Others
- By End User
- Hospitals & Clinics
- Diagnostic Centers
- Ambulatory Care Centers
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- Koninklijke Philips N.V.
- General Electric Company
- Esaote SpA
- NeuroLogica Corporation
- Masimo Corporation
- York Instruments Ltd.
- Neusoft Medical Systems
- Canon Medical Systems Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Disease Indication
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Neurological Disorder Diagnostics Market, By Technology, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Imaging
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- In Vitro Diagnostics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Neurological Disorder Diagnostics Market, By Disease Indication, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Genetic Neurological Disorders
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Immunological Neurological Disorders
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Paraneoplastic Syndrome
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Paraproteinemic Neuropathies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Neurological Disorder Diagnostics Market, By End User, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals & Clinics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Diagnostics Centers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Ambulatory Care Centers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Neurological Disorder Diagnostics Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Siemens Healthineers
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Koninklijke Philips N.V.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- General Electric Company
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Esaote SpA
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- NeuroLogica Corporation
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Masimo Corporation
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- York Instruments Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Neusoft Medical Systems
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Canon Medical Systems Corporation
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Siemens Healthineers
9. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. Section
- References
- Research Methodology
- About Us and Sales Contact
샘플 요청 목록